Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022

SELL
$43.66 - $61.0 $481,089 - $672,159
-11,019 Reduced 1.1%
991,562 $53.4 Million
Q2 2022

Aug 09, 2022

SELL
$28.82 - $77.35 $5.71 Million - $15.3 Million
-198,093 Reduced 16.5%
1,002,581 $40.4 Million
Q1 2022

May 11, 2022

SELL
$48.25 - $100.49 $1.83 Million - $3.81 Million
-37,951 Reduced 3.06%
1,200,674 $79.5 Million
Q4 2021

Feb 10, 2022

BUY
$88.71 - $120.43 $9.54 Million - $12.9 Million
107,528 Added 9.51%
1,238,625 $124 Million
Q3 2021

Nov 10, 2021

SELL
$98.77 - $132.17 $5.48 Million - $7.33 Million
-55,460 Reduced 4.67%
1,131,097 $141 Million
Q2 2021

Aug 13, 2021

BUY
$109.77 - $165.68 $6.87 Million - $10.4 Million
62,540 Added 5.56%
1,186,557 $147 Million
Q1 2021

May 13, 2021

BUY
$127.04 - $179.1 $5.29 Million - $7.46 Million
41,649 Added 3.85%
1,124,017 $172 Million
Q4 2020

Feb 12, 2021

SELL
$99.96 - $135.93 $96,961 - $131,852
-970 Reduced 0.09%
1,082,368 $139 Million
Q3 2020

Nov 12, 2020

BUY
$80.32 - $111.8 $2.13 Million - $2.97 Million
26,545 Added 2.51%
1,083,338 $121 Million
Q2 2020

Aug 11, 2020

BUY
$60.49 - $97.5 $25.8 Million - $41.5 Million
425,973 Added 67.53%
1,056,793 $85.7 Million
Q1 2020

May 14, 2020

BUY
$59.04 - $88.81 $3.08 Million - $4.63 Million
52,175 Added 9.02%
630,820 $43.9 Million
Q4 2019

Feb 13, 2020

BUY
$59.49 - $82.78 $8.63 Million - $12 Million
145,085 Added 33.46%
578,645 $45.2 Million
Q3 2019

Nov 05, 2019

BUY
$62.59 - $110.3 $3.72 Million - $6.55 Million
59,426 Added 15.88%
433,560 $27.7 Million
Q2 2019

Aug 14, 2019

BUY
$63.94 - $91.11 $4.22 Million - $6.02 Million
66,065 Added 21.44%
374,134 $32.3 Million
Q1 2019

May 13, 2019

SELL
$34.3 - $97.98 $5.01 Million - $14.3 Million
-145,919 Reduced 32.14%
308,069 $23.6 Million
Q4 2018

Feb 08, 2019

BUY
$29.2 - $46.1 $13.3 Million - $20.9 Million
453,988 New
453,988 $17.1 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.64B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.